Published in Ann Intern Med on September 22, 2015
Asthma phenotypes: the intriguing selective intervention with Montelukast. Asthma Res Pract (2016) 0.87
The leukotriene receptor antagonist montelukast and its possible role in the cardiovascular field. Eur J Clin Pharmacol (2017) 0.78
Lipid Mediators of Allergic Disease: Pathways, Treatments, and Emerging Therapeutic Targets. Curr Allergy Asthma Rep (2016) 0.78
Therapeutic effect of budesonide/formoterol, montelukast and N-acetylcysteine for bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation. Respir Res (2016) 0.76
Measuring inconsistency in meta-analyses. BMJ (2003) 128.20
Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007. J Allergy Clin Immunol (2007) 15.45
The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy (2004) 13.16
Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol (2004) 8.70
Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax (1992) 5.37
Asthma: defining of the persistent adult phenotypes. Lancet (2006) 4.78
Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group. Ann Intern Med (1999) 4.45
Clinical trial of low-dose theophylline and montelukast in patients with poorly controlled asthma. Am J Respir Crit Care Med (2006) 4.35
The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma. European Network for Understanding Mechanisms of Severe Asthma. Eur Respir J (2003) 4.08
Development and validation of the Mini Asthma Quality of Life Questionnaire. Eur Respir J (1999) 4.00
Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction. N Engl J Med (1998) 3.05
Effects of montelukast and beclomethasone on airway function and asthma control. J Allergy Clin Immunol (2002) 2.41
A Web-based archive of systematic review data. Syst Rev (2012) 1.93
Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial. Am J Respir Crit Care Med (2002) 1.90
Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group. Arch Intern Med (1998) 1.85
Randomized trial of the effect of drug presentation on asthma outcomes: the American Lung Association Asthma Clinical Research Centers. J Allergy Clin Immunol (2009) 1.81
Fluticasone propionate nasal spray is superior to montelukast for allergic rhinitis while neither affects overall asthma control. Chest (2005) 1.66
Montelukast improves regional air-trapping due to small airways obstruction in asthma. Eur Respir J (2006) 1.61
Montelukast added to inhaled beclomethasone in treatment of asthma. Montelukast/Beclomethasone Additivity Group. Am J Respir Crit Care Med (1999) 1.50
Montelukast reduces airway eosinophilic inflammation in asthma: a randomized, controlled trial. Eur Respir J (1999) 1.48
Two first-line therapies in the treatment of mild asthma: use of peak flow variability as a predictor of effectiveness. Ann Allergy Asthma Immunol (1999) 1.48
Effects of pranlukast administration on vascular endothelial growth factor levels in asthmatic patients. Chest (2004) 1.48
A randomized, double-blind trial of the effect of treatment with montelukast on bronchial hyperresponsiveness and serum eosinophilic cationic protein (ECP), soluble interleukin 2 receptor (sIL-2R), IL-4, and soluble intercellular adhesion molecule 1 (sICAM-1) in children with asthma. J Allergy Clin Immunol (2002) 1.43
Adverse effects of inhaled corticosteroids. Am J Med (1995) 1.39
Effects of 6 weeks of therapy with oral doses of ICI 204,219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma. ACCOLATE Asthma Trialists Group. Am J Respir Crit Care Med (1994) 1.28
Effect of montelukast added to inhaled budesonide on control of mild to moderate asthma. Thorax (2003) 1.22
Zafirlukast for symptomatic mild-to-moderate asthma: a 13-week multicenter study. The Zafirlukast Trialists Group. Clin Ther (1997) 1.06
Montelukast as add-on therapy to inhaled corticosteroids in the treatment of mild to moderate asthma: a systematic review. Thorax (2008) 1.04
Anti-leukotrienes as add-on therapy to inhaled glucocorticoids in patients with asthma: systematic review of current evidence. BMJ (2002) 1.04
The effect of montelukast on rhinitis symptoms in patients with asthma and seasonal allergic rhinitis. Curr Med Res Opin (2004) 1.04
Reduction of eosinophilic inflammation in the airways of patients with asthma using montelukast. Chest (2002) 1.02
Azithromycin or montelukast as inhaled corticosteroid-sparing agents in moderate-to-severe childhood asthma study. J Allergy Clin Immunol (2008) 0.98
A placebo-controlled, dose-ranging study of montelukast, a cysteinyl leukotriene-receptor antagonist. Montelukast Asthma Study Group. J Allergy Clin Immunol (1998) 0.97
Clinical safety and tolerability of montelukast, a leukotriene receptor antagonist, in controlled clinical trials in patients aged > or = 6 years. Clin Exp Allergy (2001) 0.95
Comparison of asthma treatment given in addition to inhaled corticosteroids on airway inflammation and responsiveness. Eur Respir J (2006) 0.94
Fluticasone propionate compared with zafirlukast in controlling persistent asthma: a randomized double-blind, placebo-controlled trial. J Fam Pract (2001) 0.92
Effect of the leukotriene receptor antagonist pranlukast on cellular infiltration in the bronchial mucosa of patients with asthma. Thorax (1998) 0.91
Effectiveness of montelukast in the treatment of cough variant asthma. Ann Allergy Asthma Immunol (2004) 0.90
Effect of montelukast for treatment of asthma in cigarette smokers. J Allergy Clin Immunol (2013) 0.90
Comparative effects of desloratadine versus montelukast on asthma symptoms and use of beta 2-agonists in patients with seasonal allergic rhinitis and asthma. Int Arch Allergy Immunol (2003) 0.90
A randomized, double-blind trial of the effect of glucocorticoid, antileukotriene and beta-agonist treatment on IL-10 serum levels in children with asthma. Clin Exp Allergy (2002) 0.90
A comparison of the effects of oral montelukast and inhaled salmeterol on response to rescue bronchodilation after challenge. Respir Med (2004) 0.89
Zafirlukast improves asthma symptoms and quality of life in patients with moderate reversible airflow obstruction. J Allergy Clin Immunol (1998) 0.88
Dose reduction of inhaled corticosteroids under concomitant medication with montelukast in patients with asthma. Eur Respir J (2002) 0.87
A randomized, double-blind trial of the effect of anti-asthma treatment on lung function in children with asthma. Pulm Pharmacol Ther (2006) 0.85
Pranlukast, a novel leukotriene receptor antagonist: results of the first European, placebo controlled, multicentre clinical study in asthma. Thorax (1997) 0.84
Leukotriene receptor antagonist, montelukast, can reduce the need for inhaled steroid while maintaining the clinical stability of asthmatic patients. Clin Exp Allergy (2002) 0.84
The effects of add-on zafirlukast treatment to budesonide on bronchial hyperresponsiveness and serum levels of eosinophilic cationic protein and total antioxidant capacity in asthmatic patients. Tohoku J Exp Med (2004) 0.84
Distribution of therapeutic response in asthma control between oral montelukast and inhaled beclomethasone. Eur Respir J (2003) 0.83
Improvements in distal lung function correlate with asthma symptoms after treatment with oral montelukast. Chest (2006) 0.83
Steroid naive eosinophilic asthma: anti-inflammatory effects of fluticasone and montelukast. Thorax (2005) 0.82
No effect of montelukast on asthma-like symptoms in elite ice hockey players. Allergy (2004) 0.82
Bronchoprotective effects of leukotriene receptor antagonists in asthma: a meta-analysis. Chest (2002) 0.82
Zafirlukast improves pulmonary function in patients with moderate persistent asthma receiving regular inhaled steroids: a prospective randomized control study. Chang Gung Med J (2003) 0.80
Anti-inflammatory properties of montelukast, a leukotriene receptor antagonist in patients with asthma and nasal polyposis. J Investig Allergol Clin Immunol (2011) 0.80
Effect of pranlukast on bronchial inflammation in patients with asthma. Clin Exp Allergy (2000) 0.80
Failure of montelukast to reduce sputum eosinophilia in high-dose corticosteroid-dependent asthma. Eur Respir J (2005) 0.80
Clinical effects of pranlukast, an oral leukotriene receptor antagonist, in mild-to-moderate asthma: a 4 week randomized multicentre controlled trial. Respirology (2001) 0.79
Effect of montelukast on peripheral airflow obstruction in children with asthma. Ann Allergy Asthma Immunol (2006) 0.79
Montelukast improves air trapping, not airway remodeling, in patients with moderate-to-severe asthma: a pilot study. Chin Med J (Engl) (2013) 0.78
Tolerance and rebound with zafirlukast in patients with persistent asthma. J Negat Results Biomed (2008) 0.78
Montelukast for the high impact of asthma exacerbations in Venezuela: a practical and valid approach for Latin America? World Allergy Organ J (2014) 0.76
Effect of montelukast on excessive airway narrowing response to methacholine in adult asthmatic patients not on controller therapy. Allergy Asthma Proc (2009) 0.76
A new equation to estimate glomerular filtration rate. Ann Intern Med (2009) 71.41
Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis (2008) 15.04
Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med (2012) 14.99
Self-management education for adults with type 2 diabetes: a meta-analysis of the effect on glycemic control. Diabetes Care (2002) 10.00
The case of the misleading funnel plot. BMJ (2006) 8.26
Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ (2011) 6.80
Evaluation of the modification of diet in renal disease study equation in a large diverse population. J Am Soc Nephrol (2007) 6.00
Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int (2008) 5.90
Correlation of quality measures with estimates of treatment effect in meta-analyses of randomized controlled trials. JAMA (2002) 5.81
Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis. Ann Intern Med (2003) 5.47
n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review. Am J Clin Nutr (2006) 5.43
Systematic review: Vitamin D and cardiometabolic outcomes. Ann Intern Med (2010) 5.36
Impact of creatinine calibration on performance of GFR estimating equations in a pooled individual patient database. Am J Kidney Dis (2007) 5.06
Meta-analysis: the effect of dietary counseling for weight loss. Ann Intern Med (2007) 4.54
The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med (2015) 4.49
A randomized trial of tai chi for fibromyalgia. N Engl J Med (2010) 4.37
Comparison of drug dosing recommendations based on measured GFR and kidney function estimating equations. Am J Kidney Dis (2009) 4.30
Comparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study equations for estimating GFR levels above 60 mL/min/1.73 m2. Am J Kidney Dis (2010) 3.87
Comparative effectiveness of pharmacologic interventions for knee osteoarthritis: a systematic review and network meta-analysis. Ann Intern Med (2015) 3.75
Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials. Ann Intern Med (2012) 3.63
Vitamin D and calcium: a systematic review of health outcomes. Evid Rep Technol Assess (Full Rep) (2009) 3.51
Why clinicians are natural bayesians. BMJ (2005) 3.41
Pneumothorax following thoracentesis: a systematic review and meta-analysis. Arch Intern Med (2010) 3.33
Maternal obesity and risk of gestational diabetes mellitus. Diabetes Care (2007) 3.27
Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis. AIDS (2007) 3.22
Combined Diet and Physical Activity Promotion Programs to Prevent Type 2 Diabetes Among Persons at Increased Risk: A Systematic Review for the Community Preventive Services Task Force. Ann Intern Med (2015) 3.11
Meta-Analyst: software for meta-analysis of binary, continuous and diagnostic data. BMC Med Res Methodol (2009) 2.92
Loss to analysis in randomized controlled trials in CKD. Am J Kidney Dis (2011) 2.85
In an empirical evaluation of the funnel plot, researchers could not visually identify publication bias. J Clin Epidemiol (2005) 2.77
KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary. Kidney Int (2009) 2.72
Maternal obesity and risk of stillbirth: a metaanalysis. Am J Obstet Gynecol (2007) 2.66
Tai Chi is effective in treating knee osteoarthritis: a randomized controlled trial. Arthritis Rheum (2009) 2.63
Clinical practice guidelines in nephrology--for worse or for better. Nephrol Dial Transplant (2006) 2.58
Lipid-lowering therapy in persons with chronic kidney disease: a systematic review and meta-analysis. Ann Intern Med (2012) 2.51
Individual patient- versus group-level data meta-regressions for the investigation of treatment effect modifiers: ecological bias rears its ugly head. Stat Med (2002) 2.49
Randomized ICU trials do not demonstrate an association between interventions that reduce delirium duration and short-term mortality: a systematic review and meta-analysis. Crit Care Med (2014) 2.45
Adjusting for publication bias in the presence of heterogeneity. Stat Med (2003) 2.42
Graft use in transvaginal pelvic organ prolapse repair: a systematic review. Obstet Gynecol (2008) 2.31
Prior environmental contamination increases the risk of acquisition of vancomycin-resistant enterococci. Clin Infect Dis (2008) 2.19
Incidence and management of graft erosion, wound granulation, and dyspareunia following vaginal prolapse repair with graft materials: a systematic review. Int Urogynecol J (2011) 2.18
Timing of renal replacement therapy initiation in acute renal failure: a meta-analysis. Am J Kidney Dis (2008) 2.10
Association between estrogen receptor alpha gene variation and cardiovascular disease. JAMA (2003) 2.10
Long-term effectiveness of lifestyle and behavioral weight loss interventions in adults with type 2 diabetes: a meta-analysis. Am J Med (2004) 2.07
Long-Term Health Outcomes in Women With Silicone Gel Breast Implants: A Systematic Review. Ann Intern Med (2015) 2.04
Long-term effectiveness of weight-loss interventions in adults with pre-diabetes: a review. Am J Prev Med (2005) 2.04
Semi-automated screening of biomedical citations for systematic reviews. BMC Bioinformatics (2010) 2.00
Therapeutic trajectory of hyaluronic acid versus corticosteroids in the treatment of knee osteoarthritis: a systematic review and meta-analysis. Arthritis Rheum (2009) 1.99
Evaluating the performance of equations for estimating glomerular filtration rate. J Nephrol (2008) 1.95
Cancer risk with tumor necrosis factor alpha (TNF) inhibitors: meta-analysis of randomized controlled trials of adalimumab, etanercept, and infliximab using patient level data. Pharmacoepidemiol Drug Saf (2010) 1.95
Ethnic subgroup differences in hypertension in Pakistan. J Hypertens (2003) 1.94
A Web-based archive of systematic review data. Syst Rev (2012) 1.93
Efficacy of pharmacotherapy for weight loss in adults with type 2 diabetes mellitus: a meta-analysis. Arch Intern Med (2004) 1.93
Changes in dietary protein intake has no effect on serum cystatin C levels independent of the glomerular filtration rate. Kidney Int (2010) 1.88
Individual (N-of-1) trials can be combined to give population comparative treatment effect estimates: methodologic considerations. J Clin Epidemiol (2010) 1.85
Achieved versus intended pulse oximeter saturation in infants born less than 28 weeks' gestation: the AVIOx study. Pediatrics (2006) 1.83
Evaluation of the Chronic Kidney Disease Epidemiology Collaboration equation for estimating the glomerular filtration rate in multiple ethnicities. Kidney Int (2010) 1.81
Variation in estrogen-related genes and cross-sectional and longitudinal blood pressure in the Framingham Heart Study. J Hypertens (2005) 1.77
Serum creatinine as marker of kidney function in South Asians: a study of reduced GFR in adults in Pakistan. J Am Soc Nephrol (2005) 1.76
Tai Chi on psychological well-being: systematic review and meta-analysis. BMC Complement Altern Med (2010) 1.76
Dose of erythropoiesis-stimulating agents and adverse outcomes in CKD: a metaregression analysis. Am J Kidney Dis (2012) 1.69
American College of Rheumatology report on reasonable use of musculoskeletal ultrasonography in rheumatology clinical practice. Arthritis Care Res (Hoboken) (2012) 1.63
Heterogeneity of the phenotypic definition of coronary artery disease and its impact on genetic association studies. Circ Cardiovasc Genet (2010) 1.62
Effectiveness and Implications of Alternative Placebo Treatments: A Systematic Review and Network Meta-analysis of Osteoarthritis Trials. Ann Intern Med (2015) 1.61
Nonsurgical management of heavy menstrual bleeding: a systematic review. Obstet Gynecol (2013) 1.57
Vaginal estrogen use in postmenopausal women with pelvic floor disorders: systematic review and practice guidelines. Int Urogynecol J (2014) 1.56
Systematic review: reliability of compendia methods for off-label oncology indications. Ann Intern Med (2009) 1.55
Self-measured blood pressure monitoring in the management of hypertension: a systematic review and meta-analysis. Ann Intern Med (2013) 1.53
Effects of study precision and risk of bias in networks of interventions: a network meta-epidemiological study. Int J Epidemiol (2013) 1.50
Maternal obesity and risk of neural tube defects: a metaanalysis. Am J Obstet Gynecol (2008) 1.49
Bleeding complications of native kidney biopsy: a systematic review and meta-analysis. Am J Kidney Dis (2012) 1.46
Development and validation of GFR-estimating equations using diabetes, transplant and weight. Nephrol Dial Transplant (2009) 1.46
Injection of botulinum toxin for treatment of chronic lateral epicondylitis: systematic review and meta-analysis. Semin Arthritis Rheum (2010) 1.46
The vulnerable atherosclerotic plaque: scope of the literature. Ann Intern Med (2010) 1.40
Lifestyle Intervention for Weight Loss and Cardiometabolic Changes in the Setting of Glucokinase Regulatory Protein Inhibition: Glucokinase Regulatory Protein-Leu446Pro Variant in Look AHEAD. Circ Cardiovasc Genet (2015) 1.38
Performance of creatinine and cystatin C GFR estimating equations in an HIV-positive population on antiretrovirals. J Acquir Immune Defic Syndr (2012) 1.38
GFR at initiation of dialysis and mortality in CKD: a meta-analysis. Am J Kidney Dis (2012) 1.35
External validity of predictive models: a comparison of logistic regression, classification trees, and neural networks. J Clin Epidemiol (2003) 1.35
Venous thromboembolism prophylaxis in gynecologic surgery: a systematic review. Obstet Gynecol (2011) 1.31
Systematic review: association of low-density lipoprotein subfractions with cardiovascular outcomes. Ann Intern Med (2009) 1.30
The rate of progression of renal disease may not be slower in women compared with men: a patient-level meta-analysis. Nephrol Dial Transplant (2003) 1.30
Children in South Asia have higher body mass-adjusted blood pressure levels than white children in the United States: a comparative study. Circulation (2005) 1.28
Intersite differences in weight growth velocity of extremely premature infants. Pediatrics (2002) 1.28
Active surveillance in men with localized prostate cancer: a systematic review. Ann Intern Med (2012) 1.24
Auto-titrating versus fixed continuous positive airway pressure for the treatment of obstructive sleep apnea: a systematic review with meta-analyses. Syst Rev (2012) 1.24
Systematic review: comparative effectiveness of radiofrequency catheter ablation for atrial fibrillation. Ann Intern Med (2009) 1.21
Effect of frequent or extended hemodialysis on cardiovascular parameters: a meta-analysis. Am J Kidney Dis (2012) 1.17
Vaginal estrogen for genitourinary syndrome of menopause: a systematic review. Obstet Gynecol (2014) 1.17
Off-pump coronary artery bypass surgery and acute kidney injury: a meta-analysis of randomized controlled trials. Clin J Am Soc Nephrol (2010) 1.17
Interferon treatment in hemodialysis patients with chronic hepatitis C virus infection: a systematic review of the literature and meta-analysis of treatment efficacy and harms. Am J Kidney Dis (2008) 1.17
The impact of COPD on management and outcomes of patients hospitalized with acute myocardial infarction: a 10-year retrospective observational study. Chest (2011) 1.16
Single-patient (n-of-1) trials: a pragmatic clinical decision methodology for patient-centered comparative effectiveness research. J Clin Epidemiol (2013) 1.14
Hospital ownership and quality of care: what explains the different results in the literature? Health Econ (2008) 1.14
Drug use and other risk factors related to lower body mass index among HIV-infected individuals. Drug Alcohol Depend (2008) 1.13
Estrogen receptor-alpha variants are associated with lipoprotein size distribution and particle levels in women: the Framingham Heart Study. Atherosclerosis (2005) 1.13
Tai Chi for treating knee osteoarthritis: designing a long-term follow up randomized controlled trial. BMC Musculoskelet Disord (2008) 1.13
Two methods provide similar signals for the need to update systematic reviews. J Clin Epidemiol (2012) 1.12
Impact of axillary lymph node dissection on breast cancer outcome in clinically node negative patients: a systematic review and meta-analysis. Cancer (2009) 1.10
Short- and long-term effects of alkali therapy in chronic kidney disease: a systematic review. Am J Nephrol (2012) 1.09